187 related articles for article (PubMed ID: 35380413)
1. Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency.
Ncube BM; Dube A; Ward K
Pharmaceut Med; 2022 Apr; 36(2):83-97. PubMed ID: 35380413
[TBL] [Abstract][Full Text] [Related]
2. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
Ncube BM; Dube A; Ward K
J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
[TBL] [Abstract][Full Text] [Related]
3. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
[TBL] [Abstract][Full Text] [Related]
4. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
Ncube BM; Dube A; Ward K
Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
[TBL] [Abstract][Full Text] [Related]
5. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
Ncube BM; Dube A; Ward K
Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
[TBL] [Abstract][Full Text] [Related]
6. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
[TBL] [Abstract][Full Text] [Related]
7. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
Narsai K; Williams A; Mantel-Teeuwisse AK
South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
[TBL] [Abstract][Full Text] [Related]
8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
9. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
[TBL] [Abstract][Full Text] [Related]
10. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
[TBL] [Abstract][Full Text] [Related]
11. Medicines Regulation in Africa: Current State and Opportunities.
Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
[TBL] [Abstract][Full Text] [Related]
12. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European Medicines Agency?
Doua JY; Van Geertruyden JP
Trop Med Int Health; 2014 Jan; 19(1):23-36. PubMed ID: 24134396
[TBL] [Abstract][Full Text] [Related]
13. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
14. Regulation of blood services in Africa.
Ansah JK; Kafere C; Loua A; Nkansah E; Acquah ME; Mudyiwenyama L
Transfus Clin Biol; 2021 May; 28(2):148-153. PubMed ID: 33516886
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the global pharmacy workforce capacity trends from 2006 to 2012.
Bates I; John C; Seegobin P; Bruno A
Hum Resour Health; 2018 Jan; 16(1):3. PubMed ID: 29325554
[TBL] [Abstract][Full Text] [Related]
16. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
Shabangu PP; Kuwana RJ; Dube A
Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
[TBL] [Abstract][Full Text] [Related]
17. The WHO Global Benchmarking Tool: a game changer for strengthening national regulatory capacity.
Guzman J; O'Connell E; Kikule K; Hafner T
BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32784212
[TBL] [Abstract][Full Text] [Related]
18. Situation analysis on the regulation of nanomedicines in Southern Africa.
Mudyiwenyama LG; Khoza S; Dube A
Front Med (Lausanne); 2023; 10():1098830. PubMed ID: 37153083
[TBL] [Abstract][Full Text] [Related]
19. The african health profession regulatory collaborative for nurses and midwives.
McCarthy CF; Riley PL
Hum Resour Health; 2012 Aug; 10():26. PubMed ID: 22931501
[TBL] [Abstract][Full Text] [Related]
20. Industrial perceptions of medicines regulatory harmonization in the East African Community.
Dansie LS; Odoch WD; Årdal C
PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
